Abstract
AbstractThe 1-aryl-tetrahydroisoquinoline (1-aryl-THIQ) moiety is found in many biologically active molecules. Single enantiomer chemical syntheses are challenging and although some biocatalytic routes have been reported, the substrate scope is limited to certain structural motifs. The enzyme norcoclaurine synthase (NCS), involved in plant alkaloid biosynthesis, has been shown to perform stereoselective Pictet–Spengler reactions between dopamine and several carbonyl substrates. Here, benzaldehydes are explored as substrates and found to be accepted by both wild-type and mutant constructs of NCS. In particular, the variant M97V gives a range of (1 S)-aryl-THIQs in high yields (48–99%) and e.e.s (79–95%). A co-crystallised structure of the M97V variant with an active site reaction intermediate analogue is also obtained with the ligand in a pre-cyclisation conformation, consistent with (1 S)-THIQs formation. Selected THIQs are then used with catechol O-methyltransferases with exceptional regioselectivity. This work demonstrates valuable biocatalytic approaches to a range of (1 S)-THIQs.
Publisher
Springer Science and Business Media LLC
Subject
Materials Chemistry,Biochemistry,Environmental Chemistry,General Chemistry
Reference51 articles.
1. Chapa, J. D. La et al. Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types. Bioorg. Med. Chem. 27, 208–215 (2019).
2. Burks, H. E. et al. 1,2,3,4-Tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders. Patent WO2015092634A1 (2015).
3. Cheng, P. et al. 1-Aryl-tetrahydroisoquinoline analogs as active anti-HIV agents in vitro. Bioorg. Med. Chem. Lett. 18, 2475–2478 (2008).
4. Coppola, J. A., Paul, R. & Cohen, E. 1-(4’-Substituted-phenyl)-2-(phenyl lower alkyl)-1,2,3,4-tetrahydroisoquinolines. US patent 3,597,431 (1971).
5. Ikeda, K. et al. M3 receptor antagonism by the novel antimuscarinic agent solifenacin in urinary bladder and salivary gland. Naunyn. Schmiedebergs. Arch. Pharmacol. 366, 97–103 (2002).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献